Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method
- 1 July 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (1) , 20-28
- https://doi.org/10.1016/s0168-8278(98)80174-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2bHepatology, 1993
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisGastroenterology, 1991
- Hepatic Fibrosis — New Therapeutic ApproachesNew England Journal of Medicine, 1991
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- γ–Interferon Treatment Inhibits Collagen Deposition in Murine SchistosomiasisHepatology, 1989
- Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alphaDigestive Diseases and Sciences, 1989
- Selective inhibition of human diploid fibroblast collagen synthesis by interferons.Journal of Clinical Investigation, 1984
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981